Search for: "WYETH PHARMACEUTICALS COMPANY" Results 461 - 480 of 547
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Nov 2009, 3:13 pm
Wyeth’s massive reserve for Fen-Phen litigation is $21 billion,[6] and Merck’s exposure to Vioxx lawsuits may total as much as $50 billion.[7] Such figures are astronomical in comparison with these companies’ individual budgets, representing nine to twelve times each company’s annual research and development costs.[8] In fact, since each drug was only widely used for about four years, the… [read post]
24 Dec 2009, 11:32 am by Beck, et al.
For years the Alabama Attorney General has been using gullible juries and questionable "fraud" claims to extract large settlements and even larger judgments from out-of-state pharmaceutical companies. [read post]
23 Aug 2008, 1:23 am
: (Part 1 - SPICY IP), (Part 2 - SPICY IP)   Global – Copyright International Federation of the Phonographic Industry (IFPI): ‘Three strikes’ effort hit worldwide home run: (Ars Technica), How to attribute a Creative Commons licensed work: (Molly Kleinman), Chrysalis disappoints, as new artists fail to incubate: (IP finance), DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt)     Events 26 August:… [read post]
6 Jun 2008, 6:49 am
: (Spicy IP)   Events 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First meeting with Spanish Judges of the Community Trade Mark Courts’ – Alicante: (Class 46), 13-14 June: Centre for European Economic Research conference on ‘The… [read post]
5 Apr 2013, 1:01 pm by Bexis
Wyeth, Inc., 2012 WL 79670, at *7 (W.D.N.C. [read post]
23 May 2008, 1:03 am
– Discussion of Catherine Tremblay’s article on cost approach: (IP finance), US Congress cites free expression as reason ICANN must remain controlled by US government: (IP Justice), A new organisation around IP in your company? [read post]
1 Oct 2009, 2:14 am
The removing defendant, a diverse drug company (of course!) [read post]
3 Jun 2010, 1:37 pm by Bexis
Wyeth-Ayerst Laboratories, 385 F.3d 961 (6th Cir. 2004); White v. [read post]
7 Apr 2011, 4:45 am by Maxwell Kennerly
All of those claims lost but one, the failure-to-warn, which survived thanks to Wyeth v. [read post]
27 Jan 2010, 3:00 am
Lupin Ltd. concerning LoSeasonique and Takeda Pharmaceutical Company Limited et al v. [read post]
24 Dec 2008, 8:12 am
He was sentenced to six years for his role in the scheme, which netted more than $6 million from the drug company Wyeth. [read post]